2453 — Concord Healthcare Co Income Statement
0.000.00%
- HK$4.67bn
- HK$8.00bn
- CNY388.31m
Annual income statement for Concord Healthcare Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 166 | 471 | 472 | 539 | 388 |
Cost of Revenue | |||||
Gross Profit | 7.35 | -47.1 | -143 | -65.1 | -67.2 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 441 | 871 | 845 | 862 | 764 |
Operating Profit | -274 | -401 | -372 | -323 | -375 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -598 | -836 | -647 | -433 | -486 |
Provision for Income Taxes | |||||
Net Income After Taxes | -591 | -831 | -637 | -426 | -485 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -583 | -817 | -541 | -373 | -443 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -583 | -817 | -541 | -373 | -443 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.816 | -1.17 | -0.753 | -0.515 | -0.582 |